Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
PETS 
PetMed Express Inc (PETS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/02/2025: PETS (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
2 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $3
1 Year Target Price $3
| 0 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 9.41% | Avg. Invested days 43 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 09/02/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 62.38M USD | Price to earnings Ratio 302 | 1Y Target Price 3 |
Price to earnings Ratio 302 | 1Y Target Price 3 | ||
Volume (30-day avg) 2 | Beta 0.82 | 52 Weeks Range 2.81 - 6.85 | Updated Date 09/2/2025 |
52 Weeks Range 2.81 - 6.85 | Updated Date 09/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.01 |
Earnings Date
Report Date 2025-08-11 | When After Market | Estimate 0.21 | Actual -0.06 |
Profitability
Profit Margin 0.15% | Operating Margin (TTM) -0.85% |
Management Effectiveness
Return on Assets (TTM) 0.93% | Return on Equity (TTM) 0.36% |
Valuation
Trailing PE 302 | Forward PE 17.92 | Enterprise Value 14428322 | Price to Sales(TTM) 0.25 |
Enterprise Value 14428322 | Price to Sales(TTM) 0.25 | ||
Enterprise Value to Revenue 0.06 | Enterprise Value to EBITDA 1.92 | Shares Outstanding 20656500 | Shares Floating 13702655 |
Shares Outstanding 20656500 | Shares Floating 13702655 | ||
Percent Insiders 30.81 | Percent Institutions 37.79 |
Upturn AI SWOT
PetMed Express Inc
Company Overview
History and Background
PetMed Express, Inc., operating as 1-800-PetMeds, was founded in 1996 by Marc Puleo. It pioneered the direct-to-consumer pet medication model. Over the years, it expanded its product offerings and online presence to become a leading pet pharmacy.
Core Business Areas
- Prescription Medications: Sale of prescription pet medications, including heartworm preventatives, flea and tick control, and pain relievers.
- Non-Prescription Medications and Supplies: Sale of non-prescription medications, health and nutritional supplements, and pet supplies such as food, toys, and grooming products.
Leadership and Structure
Matt Hulett is the Chief Executive Officer. The company has a board of directors overseeing its operations. The organizational structure includes departments for marketing, technology, operations, and finance.
Top Products and Market Share
Key Offerings
- Flea and Tick Control Medications: Includes brands like Frontline, Advantage, and Revolution. Market share data is not readily available, but this category contributes significantly to revenue. Competitors include Chewy, Amazon, and veterinary clinics.
- Heartworm Preventatives: Includes brands like Heartgard Plus and Interceptor Plus. Market share data is not readily available, but this category is a significant revenue driver. Competitors include Chewy, Amazon, and veterinary clinics.
- Pet Supplements: Includes a variety of vitamins, minerals, and other supplements for pet health and wellness. Competitors include Chewy, Amazon, and specialty pet stores.
Market Dynamics
Industry Overview
The pet medication and supply industry is experiencing steady growth driven by increasing pet ownership and rising pet healthcare spending. The market is becoming increasingly competitive with the rise of online retailers.
Positioning
PetMed Express is positioned as a convenient and affordable online provider of pet medications and supplies. Its competitive advantages include its established brand name, direct-to-consumer model, and focus on prescription medications.
Total Addressable Market (TAM)
The global pet care market is expected to reach over $350 billion by 2027. PetMed Express is positioned to capture a portion of this TAM through its online presence and direct-to-consumer model.
Upturn SWOT Analysis
Strengths
- Established brand recognition
- Direct-to-consumer model
- Focus on prescription medications
- Large customer base
- Experienced management team
Weaknesses
- Dependence on online sales
- Competition from larger online retailers
- Regulatory scrutiny of pet medication sales
- Customer acquisition costs
- Inventory management challenges
Opportunities
- Expansion into new product categories
- Partnerships with veterinary clinics
- International expansion
- Increased pet ownership
- Growing demand for pet healthcare products
Threats
- Increased competition from online and brick-and-mortar retailers
- Changes in regulations regarding pet medication sales
- Economic downturn impacting consumer spending
- Counterfeit medications
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- CHWY
- AMZN
- VCA
Competitive Landscape
PetMed Express faces intense competition from larger online retailers like Chewy and Amazon, as well as veterinary clinics. Its advantages include its established brand name and focus on prescription medications. Its disadvantages include its smaller scale and limited product offerings.
Growth Trajectory and Initiatives
Historical Growth: PetMed Express experienced rapid growth in its early years, but growth has slowed in recent years due to increased competition.
Future Projections: Analyst estimates for PetMed Express' future growth vary depending on market conditions and company initiatives.
Recent Initiatives: Recent initiatives may include expanding product offerings, improving customer service, and investing in marketing and technology.
Summary
PetMed Express has a strong brand name and an established presence in the online pet medication market, but faces increasing competition. It is well placed in the prescription market. The company needs to innovate its product offerings and improve its marketing efforts to drive future growth and must be careful to manage inventory.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings, industry reports, news articles, analyst estimates.
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Market share estimates may vary depending on the source.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About PetMed Express Inc
Exchange NASDAQ | Headquaters Delray Beach, FL, United States | ||
IPO Launch date 1999-04-26 | Independent Chairman of the Board, Interim CEO & President Ms. Leslie C. G. Campbell | ||
Sector Healthcare | Industry Pharmaceutical Retailers | Full time employees 287 | Website https://www.1800petmeds.com |
Full time employees 287 | Website https://www.1800petmeds.com | ||
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.